

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 6.30954971 |
| 2 | sarcomere organization (GO:0045214) | 6.07524649 |
| 3 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 5.80479130 |
| 4 | cardiac myofibril assembly (GO:0055003) | 5.70073781 |
| 5 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 5.51893256 |
| 6 | ventricular cardiac muscle cell action potential (GO:0086005) | 5.34068856 |
| 7 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 5.25774417 |
| 8 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 5.09088869 |
| 9 | cell communication involved in cardiac conduction (GO:0086065) | 4.89533312 |
| 10 | myofibril assembly (GO:0030239) | 4.83444821 |
| 11 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 4.66988388 |
| 12 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 4.66462597 |
| 13 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 4.60322420 |
| 14 | cardiac muscle contraction (GO:0060048) | 4.58231829 |
| 15 | cardiac muscle cell development (GO:0055013) | 4.42513399 |
| 16 | actomyosin structure organization (GO:0031032) | 4.38335398 |
| 17 | plasma membrane repair (GO:0001778) | 4.37099945 |
| 18 | muscle filament sliding (GO:0030049) | 4.33300572 |
| 19 | actin-myosin filament sliding (GO:0033275) | 4.33300572 |
| 20 | desmosome organization (GO:0002934) | 4.30523600 |
| 21 | skin morphogenesis (GO:0043589) | 4.25675600 |
| 22 | sequestering of extracellular ligand from receptor (GO:0035581) | 4.23419693 |
| 23 | regulation of cardioblast differentiation (GO:0051890) | 4.22837878 |
| 24 | collagen fibril organization (GO:0030199) | 4.22217107 |
| 25 | cell adhesion mediated by integrin (GO:0033627) | 4.17170974 |
| 26 | cardiac cell development (GO:0055006) | 4.16651377 |
| 27 | regulation of skeletal muscle contraction (GO:0014819) | 4.04842845 |
| 28 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 4.03837131 |
| 29 | endocardial cushion development (GO:0003197) | 4.03011469 |
| 30 | cell communication by electrical coupling (GO:0010644) | 4.01932018 |
| 31 | relaxation of cardiac muscle (GO:0055119) | 4.00968156 |
| 32 | actin-mediated cell contraction (GO:0070252) | 4.00524548 |
| 33 | cardiac muscle hypertrophy (GO:0003300) | 3.94023327 |
| 34 | regulation of actin filament-based movement (GO:1903115) | 3.92252690 |
| 35 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 3.88255941 |
| 36 | cardiac conduction (GO:0061337) | 3.80909765 |
| 37 | striated muscle hypertrophy (GO:0014897) | 3.73317444 |
| 38 | regulation of membrane repolarization (GO:0060306) | 3.72561248 |
| 39 | cardiac muscle cell action potential involved in contraction (GO:0086002) | 3.71931809 |
| 40 | regulation of sarcomere organization (GO:0060297) | 3.71633672 |
| 41 | cardiac muscle cell action potential (GO:0086001) | 3.69452309 |
| 42 | striated muscle contraction (GO:0006941) | 3.67546428 |
| 43 | regulation of heart rate by cardiac conduction (GO:0086091) | 3.65630036 |
| 44 | cardiac muscle tissue morphogenesis (GO:0055008) | 3.65061155 |
| 45 | heart trabecula formation (GO:0060347) | 3.60492374 |
| 46 | carnitine shuttle (GO:0006853) | 3.57807070 |
| 47 | tricarboxylic acid cycle (GO:0006099) | 3.57310721 |
| 48 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 3.56017143 |
| 49 | pericardium development (GO:0060039) | 3.55049195 |
| 50 | chemical homeostasis within a tissue (GO:0048875) | 3.54916151 |
| 51 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.54671485 |
| 52 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 3.47784387 |
| 53 | surfactant homeostasis (GO:0043129) | 3.46277713 |
| 54 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 3.44399475 |
| 55 | regulation of cell communication by electrical coupling (GO:0010649) | 3.43421362 |
| 56 | regulation of striated muscle contraction (GO:0006942) | 3.42924574 |
| 57 | regulation of relaxation of muscle (GO:1901077) | 3.42637915 |
| 58 | actin filament-based movement (GO:0030048) | 3.40616751 |
| 59 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 3.39369807 |
| 60 | chondrocyte proliferation (GO:0035988) | 3.38968104 |
| 61 | regulation of the force of heart contraction (GO:0002026) | 3.31240278 |
| 62 | muscle tissue morphogenesis (GO:0060415) | 3.31016055 |
| 63 | kidney mesenchyme development (GO:0072074) | 3.29396839 |
| 64 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.27699966 |
| 65 | regulation of integrin-mediated signaling pathway (GO:2001044) | 3.25452256 |
| 66 | cell migration involved in heart development (GO:0060973) | 3.25040522 |
| 67 | cell-substrate junction assembly (GO:0007044) | 3.24394462 |
| 68 | extracellular matrix assembly (GO:0085029) | 3.23695727 |
| 69 | negative regulation of fatty acid transport (GO:2000192) | 3.20640369 |
| 70 | endodermal cell differentiation (GO:0035987) | 3.20522351 |
| 71 | adult heart development (GO:0007512) | 3.18024227 |
| 72 | negative regulation of complement activation (GO:0045916) | 3.16827134 |
| 73 | fatty acid transmembrane transport (GO:1902001) | 3.16807261 |
| 74 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 3.16362060 |
| 75 | hypotonic response (GO:0006971) | 3.15854725 |
| 76 | muscle hypertrophy (GO:0014896) | 3.15457664 |
| 77 | hemidesmosome assembly (GO:0031581) | 3.14919815 |
| 78 | membrane repolarization during action potential (GO:0086011) | 3.11011262 |
| 79 | regulation of heart rate (GO:0002027) | 3.09771233 |
| 80 | substrate-dependent cell migration (GO:0006929) | 3.08646278 |
| 81 | regulation of cardiac muscle contraction (GO:0055117) | 3.07331372 |
| 82 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 3.05625100 |
| 83 | metanephric mesenchyme development (GO:0072075) | 3.01728540 |
| 84 | negative regulation of potassium ion transport (GO:0043267) | 2.97770677 |
| 85 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 2.97173238 |
| 86 | muscle hypertrophy in response to stress (GO:0003299) | 2.97173238 |
| 87 | cardiac muscle adaptation (GO:0014887) | 2.97173238 |
| 88 | glomerular basement membrane development (GO:0032836) | 2.97172061 |
| 89 | regulation of cardiac muscle cell contraction (GO:0086004) | 2.96825977 |
| 90 | detection of calcium ion (GO:0005513) | 2.96259579 |
| 91 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 2.95945052 |
| 92 | extracellular fibril organization (GO:0043206) | 2.95633060 |
| 93 | regulation of branching involved in salivary gland morphogenesis (GO:0060693) | 2.93762871 |
| 94 | endothelial cell morphogenesis (GO:0001886) | 2.92746712 |
| 95 | negative regulation of protein activation cascade (GO:2000258) | 2.92728357 |
| 96 | atrioventricular valve morphogenesis (GO:0003181) | 2.91112846 |
| 97 | regulation of heart contraction (GO:0008016) | 2.90738344 |
| 98 | membrane raft organization (GO:0031579) | 2.89298052 |
| 99 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 2.89231388 |
| 100 | cell-substrate adherens junction assembly (GO:0007045) | 2.89110900 |
| 101 | focal adhesion assembly (GO:0048041) | 2.89110900 |
| 102 | extracellular regulation of signal transduction (GO:1900115) | 2.88769036 |
| 103 | extracellular negative regulation of signal transduction (GO:1900116) | 2.88769036 |
| 104 | regulation of tight junction assembly (GO:2000810) | 2.87883570 |
| 105 | epithelial cell-cell adhesion (GO:0090136) | 2.86847252 |
| 106 | protein heterotrimerization (GO:0070208) | 2.81788825 |
| 107 | protein localization to endosome (GO:0036010) | 2.81699783 |
| 108 | positive regulation of cation channel activity (GO:2001259) | 2.79526929 |
| 109 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.78133413 |
| 110 | mesenchymal-epithelial cell signaling (GO:0060638) | 2.77474457 |
| 111 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 2.76840952 |
| 112 | response to muscle activity (GO:0014850) | 2.75376446 |
| 113 | type B pancreatic cell proliferation (GO:0044342) | 2.74549516 |
| 114 | negative regulation of protein localization to cell surface (GO:2000009) | 2.73789415 |
| 115 | positive regulation of extracellular matrix organization (GO:1903055) | 2.73676617 |
| 116 | COPII vesicle coating (GO:0048208) | 2.71907914 |
| 117 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.70470507 |
| 118 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 2.70279324 |
| 119 | regulation of calcium ion transmembrane transport (GO:1903169) | 2.70279324 |
| 120 | positive regulation of heart contraction (GO:0045823) | 2.70254702 |
| 121 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.69521623 |
| 122 | adherens junction assembly (GO:0034333) | 2.69163389 |
| 123 | bone trabecula formation (GO:0060346) | 2.68950619 |
| 124 | smooth muscle tissue development (GO:0048745) | 2.68042719 |
| 125 | barbed-end actin filament capping (GO:0051016) | 2.67957720 |
| 126 | relaxation of muscle (GO:0090075) | 2.66130529 |
| 127 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.65266642 |
| 128 | fibril organization (GO:0097435) | 2.64388353 |
| 129 | carnitine transmembrane transport (GO:1902603) | 2.63587615 |
| 130 | negative regulation of pathway-restricted SMAD protein phosphorylation (GO:0060394) | 2.62582067 |
| 131 | regulation of transforming growth factor beta1 production (GO:0032908) | 2.62116250 |
| 132 | striated muscle cell development (GO:0055002) | 2.61630735 |
| 133 | regulation of potassium ion transmembrane transporter activity (GO:1901016) | 2.61401513 |
| 134 | cell migration involved in sprouting angiogenesis (GO:0002042) | 2.60905945 |
| 135 | striated muscle adaptation (GO:0014888) | 2.60777640 |
| 136 | positive regulation of osteoblast proliferation (GO:0033690) | 2.58523034 |
| 137 | regulation of potassium ion transmembrane transport (GO:1901379) | 2.58074098 |
| 138 | fibroblast migration (GO:0010761) | 2.57423374 |
| 139 | substrate adhesion-dependent cell spreading (GO:0034446) | 2.57405717 |
| 140 | virion attachment to host cell (GO:0019062) | 2.56172969 |
| 141 | adhesion of symbiont to host cell (GO:0044650) | 2.56172969 |
| 142 | negative regulation of cardiac muscle cell apoptotic process (GO:0010667) | 2.54794139 |
| 143 | carnitine transport (GO:0015879) | 2.54083120 |
| 144 | amino-acid betaine transport (GO:0015838) | 2.54083120 |
| 145 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 2.54025209 |
| 146 | muscle contraction (GO:0006936) | 2.53872756 |
| 147 | negative regulation of stem cell proliferation (GO:2000647) | 2.51424847 |
| 148 | regulation of cofactor metabolic process (GO:0051193) | 2.49437867 |
| 149 | regulation of coenzyme metabolic process (GO:0051196) | 2.49437867 |
| 150 | regulation of transforming growth factor beta2 production (GO:0032909) | 2.49180474 |
| 151 | collagen metabolic process (GO:0032963) | 2.48318145 |
| 152 | actin filament depolymerization (GO:0030042) | 2.48054724 |
| 153 | striated muscle atrophy (GO:0014891) | 2.47309164 |
| 154 | basement membrane organization (GO:0071711) | 2.46240737 |
| 155 | muscle cell migration (GO:0014812) | 2.45901322 |
| 156 | protein localization to cell surface (GO:0034394) | 2.45876261 |
| 157 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.45495211 |
| 158 | regulation of p38MAPK cascade (GO:1900744) | 2.44768347 |
| 159 | negative regulation of ion transmembrane transporter activity (GO:0032413) | 2.44574987 |
| 160 | cellular response to vitamin (GO:0071295) | 2.44411322 |
| 161 | protein targeting to Golgi (GO:0000042) | 2.43776229 |
| 162 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 2.43757151 |
| 163 | peptide cross-linking (GO:0018149) | 2.43738506 |
| 164 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.43081153 |
| 165 | negative regulation of humoral immune response (GO:0002921) | 2.42872833 |
| 166 | regulation of ATPase activity (GO:0043462) | 2.42658446 |
| 167 | glomerular visceral epithelial cell development (GO:0072015) | 2.40785432 |
| 168 | stress fiber assembly (GO:0043149) | 2.40715433 |
| 169 | apoptotic cell clearance (GO:0043277) | 2.40665776 |
| 170 | regulation of plasminogen activation (GO:0010755) | 2.40602621 |
| 171 | multicellular organismal macromolecule metabolic process (GO:0044259) | 2.40376777 |
| 172 | wound healing, spreading of epidermal cells (GO:0035313) | 2.39410304 |
| 173 | regulation of cardiac muscle cell differentiation (GO:2000725) | 2.39017673 |
| 174 | glomerular epithelial cell development (GO:0072310) | 2.38370866 |
| 175 | Golgi transport vesicle coating (GO:0048200) | 2.37744270 |
| 176 | COPI coating of Golgi vesicle (GO:0048205) | 2.37744270 |
| 177 | negative regulation of osteoblast proliferation (GO:0033689) | 2.35626812 |
| 178 | hippo signaling (GO:0035329) | 2.34704824 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 2.94471380 |
| 2 | * EP300_21415370_ChIP-Seq_HL-1_Mouse | 2.94104888 |
| 3 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.69487757 |
| 4 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.42532853 |
| 5 | BRD4_25478319_ChIP-Seq_HGPS_Human | 2.31022514 |
| 6 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.29532280 |
| 7 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.16575368 |
| 8 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.16344969 |
| 9 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.12397507 |
| 10 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.10795994 |
| 11 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 2.02393695 |
| 12 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 2.00561950 |
| 13 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 2.00561950 |
| 14 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.94314853 |
| 15 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.89005349 |
| 16 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.87842367 |
| 17 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.87330590 |
| 18 | GATA1_22025678_ChIP-Seq_K562_Human | 1.81022050 |
| 19 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.80715407 |
| 20 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.75746540 |
| 21 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.74405260 |
| 22 | * TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.73275759 |
| 23 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.70115661 |
| 24 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.69704140 |
| 25 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.67903750 |
| 26 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.62530628 |
| 27 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.59850878 |
| 28 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.55735000 |
| 29 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.55121761 |
| 30 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.54961788 |
| 31 | * AHR_22903824_ChIP-Seq_MCF-7_Human | 1.52767699 |
| 32 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.50566580 |
| 33 | * CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.49626716 |
| 34 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.47819580 |
| 35 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.47399760 |
| 36 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.47250973 |
| 37 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.45953071 |
| 38 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.41236601 |
| 39 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.38948005 |
| 40 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.38889819 |
| 41 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.38834369 |
| 42 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.38834369 |
| 43 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.38520496 |
| 44 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.37949468 |
| 45 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.37921661 |
| 46 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.36880508 |
| 47 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.36748184 |
| 48 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.34357722 |
| 49 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.34235474 |
| 50 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.33968826 |
| 51 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.33954244 |
| 52 | * SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.32793842 |
| 53 | * ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.31005082 |
| 54 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.30918407 |
| 55 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.30474592 |
| 56 | TP53_16413492_ChIP-PET_HCT116_Human | 1.29973352 |
| 57 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.29511788 |
| 58 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.29375083 |
| 59 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.28735133 |
| 60 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.27675652 |
| 61 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.26521613 |
| 62 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.24607200 |
| 63 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.24133380 |
| 64 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.23484251 |
| 65 | CJUN_26792858_Chip-Seq_BT549_Human | 1.23092636 |
| 66 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.22344338 |
| 67 | * ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.22294378 |
| 68 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.21678236 |
| 69 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.21534981 |
| 70 | * JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.21001151 |
| 71 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.20499302 |
| 72 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.19928542 |
| 73 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.19709866 |
| 74 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.17124480 |
| 75 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.17046496 |
| 76 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.15765598 |
| 77 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.15217203 |
| 78 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.14119146 |
| 79 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.12862221 |
| 80 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.12738438 |
| 81 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.12172522 |
| 82 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.09816928 |
| 83 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.07868194 |
| 84 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.07634997 |
| 85 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.06906602 |
| 86 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.06374002 |
| 87 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.06306911 |
| 88 | * FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.06191670 |
| 89 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.06126419 |
| 90 | * PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.06002563 |
| 91 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.05833157 |
| 92 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 1.05605801 |
| 93 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.05028358 |
| 94 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.04724086 |
| 95 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.04364461 |
| 96 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 1.04350652 |
| 97 | * NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.03882859 |
| 98 | * NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.03882859 |
| 99 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.01449232 |
| 100 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.00585493 |
| 101 | KDM2B_26808549_Chip-Seq_K562_Human | 0.99601869 |
| 102 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 0.97804398 |
| 103 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.97741953 |
| 104 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.97592482 |
| 105 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 0.97486640 |
| 106 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 0.96476754 |
| 107 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.96427439 |
| 108 | * TP63_23658742_ChIP-Seq_EP156T_Human | 0.96355254 |
| 109 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.95985765 |
| 110 | * KLF5_25053715_ChIP-Seq_YYC3_Human | 0.95627328 |
| 111 | * NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.95534834 |
| 112 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.95178051 |
| 113 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.95124323 |
| 114 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.95124323 |
| 115 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.94745540 |
| 116 | RXR_22108803_ChIP-Seq_LS180_Human | 0.94297333 |
| 117 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.94170690 |
| 118 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.94035045 |
| 119 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.93979481 |
| 120 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.93662011 |
| 121 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.92472487 |
| 122 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.91795353 |
| 123 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.90839926 |
| 124 | * GATA6_25053715_ChIP-Seq_YYC3_Human | 0.90275415 |
| 125 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.89972139 |
| 126 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.89493128 |
| 127 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.89304213 |
| 128 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 0.88900475 |
| 129 | * NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.88580463 |
| 130 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.88173522 |
| 131 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.84746634 |
| 132 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.81779192 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0008438_abnormal_cutaneous_collagen | 6.37193292 |
| 2 | MP0002837_dystrophic_cardiac_calcinosis | 5.15415391 |
| 3 | MP0004084_abnormal_cardiac_muscle | 4.85282917 |
| 4 | MP0004215_abnormal_myocardial_fiber | 3.99098222 |
| 5 | MP0000751_myopathy | 3.97461080 |
| 6 | MP0005503_abnormal_tendon_morphology | 3.52304356 |
| 7 | MP0004036_abnormal_muscle_relaxation | 3.50903517 |
| 8 | MP0003646_muscle_fatigue | 3.26427124 |
| 9 | MP0005330_cardiomyopathy | 3.19929266 |
| 10 | MP0003279_aneurysm | 3.17024358 |
| 11 | MP0000749_muscle_degeneration | 2.87555373 |
| 12 | MP0010234_abnormal_vibrissa_follicle | 2.76473980 |
| 13 | MP0002972_abnormal_cardiac_muscle | 2.71860515 |
| 14 | * MP0004087_abnormal_muscle_fiber | 2.53327704 |
| 15 | MP0003137_abnormal_impulse_conducting | 2.51225782 |
| 16 | MP0004484_altered_response_of | 2.47139758 |
| 17 | MP0008775_abnormal_heart_ventricle | 2.39345296 |
| 18 | MP0005620_abnormal_muscle_contractility | 2.37348723 |
| 19 | MP0001542_abnormal_bone_strength | 2.27381346 |
| 20 | MP0006138_congestive_heart_failure | 2.23183115 |
| 21 | MP0010630_abnormal_cardiac_muscle | 2.18831531 |
| 22 | MP0004085_abnormal_heartbeat | 2.15646538 |
| 23 | MP0010352_gastrointestinal_tract_polyps | 2.15123633 |
| 24 | MP0001544_abnormal_cardiovascular_syste | 2.15059615 |
| 25 | MP0005385_cardiovascular_system_phenoty | 2.15059615 |
| 26 | MP0005257_abnormal_intraocular_pressure | 1.99100775 |
| 27 | MP0005023_abnormal_wound_healing | 1.96157331 |
| 28 | MP0003828_pulmonary_edema | 1.93624959 |
| 29 | MP0000750_abnormal_muscle_regeneration | 1.93398455 |
| 30 | MP0009780_abnormal_chondrocyte_physiolo | 1.89993144 |
| 31 | MP0010368_abnormal_lymphatic_system | 1.89816924 |
| 32 | MP0004130_abnormal_muscle_cell | 1.86677326 |
| 33 | MP0004145_abnormal_muscle_electrophysio | 1.85668896 |
| 34 | MP0002822_catalepsy | 1.84058271 |
| 35 | MP0002106_abnormal_muscle_physiology | 1.79518468 |
| 36 | MP0004043_abnormal_pH_regulation | 1.79063709 |
| 37 | MP0002108_abnormal_muscle_morphology | 1.77126018 |
| 38 | MP0002269_muscular_atrophy | 1.75959272 |
| 39 | MP0003950_abnormal_plasma_membrane | 1.71154148 |
| 40 | MP0002234_abnormal_pharynx_morphology | 1.59492974 |
| 41 | MP0003705_abnormal_hypodermis_morpholog | 1.59090963 |
| 42 | MP0002060_abnormal_skin_morphology | 1.55985805 |
| 43 | MP0000747_muscle_weakness | 1.54671525 |
| 44 | MP0004272_abnormal_basement_membrane | 1.50639645 |
| 45 | MP0002896_abnormal_bone_mineralization | 1.49490469 |
| 46 | MP0001299_abnormal_eye_distance/ | 1.46252868 |
| 47 | MP0005369_muscle_phenotype | 1.41468279 |
| 48 | MP0002909_abnormal_adrenal_gland | 1.40611898 |
| 49 | MP0004233_abnormal_muscle_weight | 1.39860084 |
| 50 | MP0003566_abnormal_cell_adhesion | 1.36306310 |
| 51 | MP0009384_cardiac_valve_regurgitation | 1.34949502 |
| 52 | MP0004510_myositis | 1.33285736 |
| 53 | MP0002127_abnormal_cardiovascular_syste | 1.31075103 |
| 54 | MP0003941_abnormal_skin_development | 1.29198335 |
| 55 | MP0009250_abnormal_appendicular_skeleto | 1.28031597 |
| 56 | * MP0000759_abnormal_skeletal_muscle | 1.24784897 |
| 57 | MP0000537_abnormal_urethra_morphology | 1.22902482 |
| 58 | MP0001765_abnormal_ion_homeostasis | 1.20433957 |
| 59 | MP0005508_abnormal_skeleton_morphology | 1.19054750 |
| 60 | MP0000534_abnormal_ureter_morphology | 1.18533111 |
| 61 | MP0004264_abnormal_extraembryonic_tissu | 1.17005783 |
| 62 | MP0010386_abnormal_urinary_bladder | 1.15841467 |
| 63 | MP0004185_abnormal_adipocyte_glucose | 1.15338272 |
| 64 | MP0005165_increased_susceptibility_to | 1.12266736 |
| 65 | MP0003221_abnormal_cardiomyocyte_apopto | 1.11569543 |
| 66 | MP0005167_abnormal_blood-brain_barrier | 1.10671499 |
| 67 | MP0005595_abnormal_vascular_smooth | 1.09808937 |
| 68 | MP0001958_emphysema | 1.08931580 |
| 69 | MP0005275_abnormal_skin_tensile | 1.07999400 |
| 70 | MP0005187_abnormal_penis_morphology | 1.07267881 |
| 71 | MP0000762_abnormal_tongue_morphology | 1.06122978 |
| 72 | MP0004859_abnormal_synaptic_plasticity | 1.05709148 |
| 73 | MP0002168_other_aberrant_phenotype | 1.04771151 |
| 74 | MP0001243_abnormal_dermal_layer | 1.04035843 |
| 75 | MP0008961_abnormal_basal_metabolism | 1.03998144 |
| 76 | MP0005666_abnormal_adipose_tissue | 1.00216570 |
| 77 | MP0000230_abnormal_systemic_arterial | 0.99769065 |
| 78 | MP0010030_abnormal_orbit_morphology | 0.99731356 |
| 79 | MP0000266_abnormal_heart_morphology | 0.96578742 |
| 80 | MP0005164_abnormal_response_to | 0.95200646 |
| 81 | MP0002295_abnormal_pulmonary_circulatio | 0.94999951 |
| 82 | MP0005085_abnormal_gallbladder_physiolo | 0.94660201 |
| 83 | MP0005409_darkened_coat_color | 0.92666369 |
| 84 | MP0000462_abnormal_digestive_system | 0.92176439 |
| 85 | MP0001666_abnormal_nutrient_absorption | 0.91788434 |
| 86 | MP0002796_impaired_skin_barrier | 0.91404169 |
| 87 | MP0003567_abnormal_fetal_cardiomyocyte | 0.91277269 |
| 88 | MP0003045_fibrosis | 0.90642099 |
| 89 | MP0000013_abnormal_adipose_tissue | 0.90144277 |
| 90 | MP0002332_abnormal_exercise_endurance | 0.89697165 |
| 91 | MP0005451_abnormal_body_composition | 0.88139358 |
| 92 | MP0004782_abnormal_surfactant_physiolog | 0.87922437 |
| 93 | MP0003300_gastrointestinal_ulcer | 0.87905566 |
| 94 | MP0001879_abnormal_lymphatic_vessel | 0.87563499 |
| 95 | MP0004134_abnormal_chest_morphology | 0.87540622 |
| 96 | MP0003191_abnormal_cellular_cholesterol | 0.86099948 |
| 97 | MP0004270_analgesia | 0.83954005 |
| 98 | MP0008004_abnormal_stomach_pH | 0.83060388 |
| 99 | MP0003868_abnormal_feces_composition | 0.81349822 |
| 100 | MP0001348_abnormal_lacrimal_gland | 0.79512830 |
| 101 | MP0003942_abnormal_urinary_system | 0.78079533 |
| 102 | MP0003091_abnormal_cell_migration | 0.76715659 |
| 103 | MP0005623_abnormal_meninges_morphology | 0.75362678 |
| 104 | MP0003385_abnormal_body_wall | 0.75214011 |
| 105 | MP0001661_extended_life_span | 0.75166997 |
| 106 | MP0005360_urolithiasis | 0.75025578 |
| 107 | MP0010678_abnormal_skin_adnexa | 0.74474104 |
| 108 | MP0005375_adipose_tissue_phenotype | 0.71460823 |
| 109 | MP0005388_respiratory_system_phenotype | 0.71358587 |
| 110 | MP0002133_abnormal_respiratory_system | 0.71358587 |
| 111 | MP0005083_abnormal_biliary_tract | 0.70741444 |
| 112 | MP0002115_abnormal_skeleton_extremities | 0.68129020 |
| 113 | MP0002128_abnormal_blood_circulation | 0.68098947 |
| 114 | MP0001756_abnormal_urination | 0.67622183 |
| 115 | MP0008875_abnormal_xenobiotic_pharmacok | 0.67514191 |
| 116 | MP0001614_abnormal_blood_vessel | 0.66865103 |
| 117 | MP0000767_abnormal_smooth_muscle | 0.66306798 |
| 118 | MP0003878_abnormal_ear_physiology | 0.66020801 |
| 119 | MP0005377_hearing/vestibular/ear_phenot | 0.66020801 |
| 120 | MP0000163_abnormal_cartilage_morphology | 0.65623365 |
| 121 | MP0003252_abnormal_bile_duct | 0.65322628 |
| 122 | MP0009840_abnormal_foam_cell | 0.63912980 |
| 123 | MP0004883_abnormal_blood_vessel | 0.63562808 |
| 124 | MP0002925_abnormal_cardiovascular_devel | 0.63103094 |
| 125 | MP0000579_abnormal_nail_morphology | 0.63063323 |
| 126 | MP0000003_abnormal_adipose_tissue | 0.62936778 |
| 127 | MP0000432_abnormal_head_morphology | 0.62743864 |
| 128 | MP0000467_abnormal_esophagus_morphology | 0.62038849 |
| 129 | MP0009643_abnormal_urine_homeostasis | 0.60883374 |
| 130 | MP0003115_abnormal_respiratory_system | 0.58026490 |
| 131 | MP0006054_spinal_hemorrhage | 0.57861995 |
| 132 | MP0002877_abnormal_melanocyte_morpholog | 0.57191377 |
| 133 | MP0000538_abnormal_urinary_bladder | 0.56897328 |
| 134 | MP0002998_abnormal_bone_remodeling | 0.56722622 |
| 135 | MP0000343_altered_response_to | 0.56067364 |
| 136 | MP0001849_ear_inflammation | 0.55523768 |
| 137 | MP0001177_atelectasis | 0.55458385 |
| 138 | MP0001664_abnormal_digestion | 0.54907186 |
| 139 | MP0006036_abnormal_mitochondrial_physio | 0.54892055 |
| 140 | MP0000733_abnormal_muscle_development | 0.53629593 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Sudden death (HP:0001699) | 7.36886857 |
| 2 | Right ventricular cardiomyopathy (HP:0011663) | 6.74742697 |
| 3 | Premature rupture of membranes (HP:0001788) | 6.15809398 |
| 4 | Protrusio acetabuli (HP:0003179) | 5.99107282 |
| 5 | Ventricular tachycardia (HP:0004756) | 5.97324560 |
| 6 | Syncope (HP:0001279) | 5.38813455 |
| 7 | Atrial fibrillation (HP:0005110) | 5.31338513 |
| 8 | Aortic aneurysm (HP:0004942) | 5.15772986 |
| 9 | Primary atrial arrhythmia (HP:0001692) | 4.99077777 |
| 10 | Aortic dissection (HP:0002647) | 4.86841518 |
| 11 | Supraventricular tachycardia (HP:0004755) | 4.73475399 |
| 12 | Calf muscle hypertrophy (HP:0008981) | 4.71773258 |
| 13 | Supraventricular arrhythmia (HP:0005115) | 4.67550766 |
| 14 | Exercise-induced myalgia (HP:0003738) | 4.53942880 |
| 15 | Hyporeflexia of lower limbs (HP:0002600) | 4.47072095 |
| 16 | Bundle branch block (HP:0011710) | 4.43930438 |
| 17 | Prolonged QT interval (HP:0001657) | 4.43152793 |
| 18 | Ventricular fibrillation (HP:0001663) | 4.40198907 |
| 19 | Vascular tortuosity (HP:0004948) | 4.34939364 |
| 20 | Muscle fiber splitting (HP:0003555) | 4.33480928 |
| 21 | Ventricular arrhythmia (HP:0004308) | 4.32045155 |
| 22 | Abnormality of the calf musculature (HP:0001430) | 4.31551752 |
| 23 | Muscle hypertrophy of the lower extremities (HP:0008968) | 4.20211190 |
| 24 | Lipoatrophy (HP:0100578) | 4.18781714 |
| 25 | Exercise-induced muscle cramps (HP:0003710) | 4.12547869 |
| 26 | Arterial tortuosity (HP:0005116) | 4.08625636 |
| 27 | Abnormality of the left ventricular outflow tract (HP:0011103) | 3.98578463 |
| 28 | Subaortic stenosis (HP:0001682) | 3.98578463 |
| 29 | Palpitations (HP:0001962) | 3.66808873 |
| 30 | Heart block (HP:0012722) | 3.62798837 |
| 31 | Nemaline bodies (HP:0003798) | 3.59927645 |
| 32 | Atrioventricular block (HP:0001678) | 3.52486803 |
| 33 | Dilated cardiomyopathy (HP:0001644) | 3.51863389 |
| 34 | Abnormal atrioventricular conduction (HP:0005150) | 3.49253891 |
| 35 | Soft skin (HP:0000977) | 3.39030035 |
| 36 | Myoglobinuria (HP:0002913) | 3.35120498 |
| 37 | Increased connective tissue (HP:0009025) | 3.33156149 |
| 38 | EMG: myopathic abnormalities (HP:0003458) | 3.22738427 |
| 39 | Round ear (HP:0100830) | 3.21039988 |
| 40 | Spinal rigidity (HP:0003306) | 3.19692206 |
| 41 | Mildly elevated creatine phosphokinase (HP:0008180) | 3.15778220 |
| 42 | Abnormal EKG (HP:0003115) | 3.14784867 |
| 43 | Asymmetric septal hypertrophy (HP:0001670) | 3.13417585 |
| 44 | Wormian bones (HP:0002645) | 3.13019700 |
| 45 | Fragile skin (HP:0001030) | 3.03000785 |
| 46 | Cardiovascular calcification (HP:0011915) | 2.96986880 |
| 47 | Difficulty running (HP:0009046) | 2.96852394 |
| 48 | Spondylolisthesis (HP:0003302) | 2.91579259 |
| 49 | Bladder diverticulum (HP:0000015) | 2.90989973 |
| 50 | Ankle contracture (HP:0006466) | 2.85351018 |
| 51 | Difficulty climbing stairs (HP:0003551) | 2.82362955 |
| 52 | Neonatal short-limb short stature (HP:0008921) | 2.81303884 |
| 53 | Follicular hyperkeratosis (HP:0007502) | 2.78781377 |
| 54 | Hyperactive renin-angiotensin system (HP:0000841) | 2.75909189 |
| 55 | Overgrowth (HP:0001548) | 2.73517825 |
| 56 | Dilatation of the ascending aorta (HP:0005111) | 2.72211473 |
| 57 | Type 1 muscle fiber predominance (HP:0003803) | 2.70525101 |
| 58 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.70524052 |
| 59 | Osteolytic defects of the hand bones (HP:0009699) | 2.70524052 |
| 60 | Mitral stenosis (HP:0001718) | 2.70305059 |
| 61 | Abnormality of dentin (HP:0010299) | 2.69812043 |
| 62 | Cervical subluxation (HP:0003308) | 2.60020590 |
| 63 | Mitral valve prolapse (HP:0001634) | 2.59602050 |
| 64 | Shallow orbits (HP:0000586) | 2.53396173 |
| 65 | Popliteal pterygium (HP:0009756) | 2.49487097 |
| 66 | Aortic regurgitation (HP:0001659) | 2.43590070 |
| 67 | Cerebral aneurysm (HP:0004944) | 2.43044514 |
| 68 | Aplasia of the musculature (HP:0100854) | 2.42640950 |
| 69 | Palmoplantar keratoderma (HP:0000982) | 2.39790459 |
| 70 | Ketoacidosis (HP:0001993) | 2.37502245 |
| 71 | Peritonitis (HP:0002586) | 2.35060767 |
| 72 | Elbow flexion contracture (HP:0002987) | 2.34446771 |
| 73 | Hypoplastic ischia (HP:0003175) | 2.32202188 |
| 74 | Genu recurvatum (HP:0002816) | 2.31262718 |
| 75 | Myotonia (HP:0002486) | 2.29537260 |
| 76 | Broad metatarsal (HP:0001783) | 2.28701303 |
| 77 | Neck muscle weakness (HP:0000467) | 2.28673181 |
| 78 | Abnormality of the acetabulum (HP:0003170) | 2.26523931 |
| 79 | Ulnar deviation of the wrist (HP:0003049) | 2.26317294 |
| 80 | Blue sclerae (HP:0000592) | 2.25550486 |
| 81 | Sudden cardiac death (HP:0001645) | 2.24103925 |
| 82 | Dysmetric saccades (HP:0000641) | 2.23140302 |
| 83 | Increased variability in muscle fiber diameter (HP:0003557) | 2.22703223 |
| 84 | Rhabdomyolysis (HP:0003201) | 2.21689343 |
| 85 | Hyperkalemia (HP:0002153) | 2.20990850 |
| 86 | Congenital malformation of the right heart (HP:0011723) | 2.20933151 |
| 87 | Double outlet right ventricle (HP:0001719) | 2.20933151 |
| 88 | Slender build (HP:0001533) | 2.20616856 |
| 89 | Distal arthrogryposis (HP:0005684) | 2.16927837 |
| 90 | Distal lower limb muscle weakness (HP:0009053) | 2.16088307 |
| 91 | Hypoglycemic coma (HP:0001325) | 2.14344301 |
| 92 | Ulnar bowing (HP:0003031) | 2.13889038 |
| 93 | Short nail (HP:0001799) | 2.12780770 |
| 94 | Mitral regurgitation (HP:0001653) | 2.12456131 |
| 95 | Hyperextensible skin (HP:0000974) | 2.11140217 |
| 96 | Vascular calcification (HP:0004934) | 2.10088404 |
| 97 | Reduced subcutaneous adipose tissue (HP:0003758) | 2.08642205 |
| 98 | Abnormal delivery (HP:0001787) | 2.08371694 |
| 99 | Left ventricular hypertrophy (HP:0001712) | 2.06061658 |
| 100 | Joint laxity (HP:0001388) | 2.03709911 |
| 101 | Distal lower limb amyotrophy (HP:0008944) | 2.03387619 |
| 102 | Hyperglycemia (HP:0003074) | 2.01931105 |
| 103 | Bowel diverticulosis (HP:0005222) | 2.00760323 |
| 104 | Abnormality of the ischium (HP:0003174) | 1.99467169 |
| 105 | Testicular atrophy (HP:0000029) | 1.98177899 |
| 106 | EMG: neuropathic changes (HP:0003445) | 1.98022453 |
| 107 | Gout (HP:0001997) | 1.97999909 |
| 108 | Limited hip movement (HP:0008800) | 1.97747503 |
| 109 | Decreased circulating renin level (HP:0003351) | 1.97043102 |
| 110 | Vertebral compression fractures (HP:0002953) | 1.97009796 |
| 111 | Scapular winging (HP:0003691) | 1.96417456 |
| 112 | Interstitial pulmonary disease (HP:0006530) | 1.94886475 |
| 113 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.94397562 |
| 114 | Striae distensae (HP:0001065) | 1.94318811 |
| 115 | Hypoplasia of the iris (HP:0007676) | 1.92590059 |
| 116 | Abnormality of carpal bone ossification (HP:0006257) | 1.90873042 |
| 117 | Aneurysm (HP:0002617) | 1.90174217 |
| 118 | Knee flexion contracture (HP:0006380) | 1.88529348 |
| 119 | Limb-girdle muscle atrophy (HP:0003797) | 1.88403884 |
| 120 | Hip contracture (HP:0003273) | 1.86910698 |
| 121 | Polycythemia (HP:0001901) | 1.86359830 |
| 122 | Wide anterior fontanel (HP:0000260) | 1.86345316 |
| 123 | Camptodactyly of toe (HP:0001836) | 1.85048674 |
| 124 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.82706847 |
| 125 | Gowers sign (HP:0003391) | 1.82390125 |
| 126 | Biconcave vertebral bodies (HP:0004586) | 1.79538546 |
| 127 | Mild short stature (HP:0003502) | 1.79023156 |
| 128 | Thin bony cortex (HP:0002753) | 1.78220558 |
| 129 | Atrophic scars (HP:0001075) | 1.77551624 |
| 130 | Proximal amyotrophy (HP:0007126) | 1.77360209 |
| 131 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 1.76388173 |
| 132 | Milia (HP:0001056) | 1.76313290 |
| 133 | Calcaneovalgus deformity (HP:0001848) | 1.75083556 |
| 134 | Abnormality of chloride homeostasis (HP:0011422) | 1.74529556 |
| 135 | Lymphangioma (HP:0100764) | 1.74065341 |
| 136 | Generalized muscle weakness (HP:0003324) | 1.73475332 |
| 137 | Breech presentation (HP:0001623) | 1.73041551 |
| 138 | Onycholysis (HP:0001806) | 1.72909675 |
| 139 | Conjunctival hamartoma (HP:0100780) | 1.72857246 |
| 140 | Ovoid vertebral bodies (HP:0003300) | 1.72499805 |
| 141 | Rectal prolapse (HP:0002035) | 1.71484580 |
| 142 | Lower limb amyotrophy (HP:0007210) | 1.70893654 |
| 143 | Visceral angiomatosis (HP:0100761) | 1.69974430 |
| 144 | Aortic valve stenosis (HP:0001650) | 1.69440201 |
| 145 | Deformed tarsal bones (HP:0008119) | 1.68795947 |
| 146 | Muscle fiber inclusion bodies (HP:0100299) | 1.68179081 |
| 147 | Osteoarthritis (HP:0002758) | 1.67878212 |
| 148 | Joint stiffness (HP:0001387) | 1.67793690 |
| 149 | Hamartoma of the eye (HP:0010568) | 1.67457777 |
| 150 | Ileus (HP:0002595) | 1.66580241 |
| 151 | Hyperaldosteronism (HP:0000859) | 1.64786358 |
| 152 | Facial diplegia (HP:0001349) | 1.64507830 |
| 153 | Congestive heart failure (HP:0001635) | 1.64506781 |
| 154 | Muscular dystrophy (HP:0003560) | 1.63262709 |
| 155 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.58712175 |
| 156 | Abnormality of renin-angiotensin system (HP:0000847) | 1.58600890 |
| 157 | Neonatal death (HP:0003811) | 1.57681380 |
| 158 | Abnormality of the foot musculature (HP:0001436) | 1.56759135 |
| 159 | Hemangiomatosis (HP:0007461) | 1.56742867 |
| 160 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.56684596 |
| 161 | Rapidly progressive (HP:0003678) | 1.56284937 |
| 162 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.55103020 |
| 163 | Muscle stiffness (HP:0003552) | 1.52047134 |
| 164 | Bradycardia (HP:0001662) | 1.51689781 |
| 165 | Cavernous hemangioma (HP:0001048) | 1.51158485 |
| 166 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.50962883 |
| 167 | Ketosis (HP:0001946) | 1.49266639 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | LMTK2 | 3.65984882 |
| 2 | TTN | 3.30972555 |
| 3 | NEK9 | 2.93358721 |
| 4 | DMPK | 2.89875687 |
| 5 | OBSCN | 2.85149628 |
| 6 | MYLK | 2.73632714 |
| 7 | PKN2 | 2.26724146 |
| 8 | TRIB3 | 2.19221026 |
| 9 | PIK3CA | 2.18229695 |
| 10 | LATS1 | 2.17184323 |
| 11 | PHKG1 | 2.07738342 |
| 12 | PHKG2 | 2.07738342 |
| 13 | PDK3 | 2.07265895 |
| 14 | PDK4 | 2.07265895 |
| 15 | TIE1 | 2.06150396 |
| 16 | LIMK1 | 1.99835806 |
| 17 | EPHA4 | 1.96141066 |
| 18 | FRK | 1.86699104 |
| 19 | KSR2 | 1.86368123 |
| 20 | STK24 | 1.78409085 |
| 21 | PIK3CG | 1.77976440 |
| 22 | RIPK1 | 1.73782164 |
| 23 | MAP3K2 | 1.72079659 |
| 24 | PAK2 | 1.62237549 |
| 25 | EPHA2 | 1.59676521 |
| 26 | WNK4 | 1.57306457 |
| 27 | PDK2 | 1.54999067 |
| 28 | AKT3 | 1.51250550 |
| 29 | FER | 1.46847737 |
| 30 | STK39 | 1.45360625 |
| 31 | TESK1 | 1.44865101 |
| 32 | MST1R | 1.42936068 |
| 33 | PAK3 | 1.36171451 |
| 34 | TAOK1 | 1.32927343 |
| 35 | MST4 | 1.31414216 |
| 36 | MAP3K9 | 1.28125944 |
| 37 | PAK4 | 1.25291517 |
| 38 | MAP3K7 | 1.24406040 |
| 39 | STK38L | 1.23995355 |
| 40 | MAP3K12 | 1.20897778 |
| 41 | EPHB2 | 1.17272206 |
| 42 | NEK1 | 1.16489949 |
| 43 | PDGFRA | 1.13539139 |
| 44 | ICK | 1.12242326 |
| 45 | MUSK | 1.10385912 |
| 46 | PRKD3 | 1.07952965 |
| 47 | INSRR | 1.07788874 |
| 48 | PRKD1 | 1.07617167 |
| 49 | CAMK2D | 1.07404460 |
| 50 | STK38 | 1.04933042 |
| 51 | MAP3K3 | 1.04222019 |
| 52 | TRPM7 | 1.02536842 |
| 53 | MAPKAPK3 | 1.00216998 |
| 54 | LATS2 | 0.99771694 |
| 55 | FGFR4 | 0.98346622 |
| 56 | PRKD2 | 0.98009672 |
| 57 | MELK | 0.97655737 |
| 58 | CDK12 | 0.95948629 |
| 59 | MOS | 0.95086887 |
| 60 | ROCK1 | 0.94971588 |
| 61 | CDC42BPA | 0.90828226 |
| 62 | PTK6 | 0.88163214 |
| 63 | PRKAA2 | 0.87623679 |
| 64 | ILK | 0.84965089 |
| 65 | ERBB4 | 0.84799187 |
| 66 | MTOR | 0.83984435 |
| 67 | PINK1 | 0.83681071 |
| 68 | DDR2 | 0.78106738 |
| 69 | MAP2K1 | 0.77323391 |
| 70 | PTK2B | 0.75464607 |
| 71 | FGFR3 | 0.75076418 |
| 72 | MAPK7 | 0.73987887 |
| 73 | NTRK3 | 0.73867812 |
| 74 | PTK2 | 0.73695439 |
| 75 | DAPK2 | 0.73319144 |
| 76 | MAP3K1 | 0.72970442 |
| 77 | TAOK3 | 0.72967596 |
| 78 | MET | 0.72008576 |
| 79 | PRKAA1 | 0.71238312 |
| 80 | PDPK1 | 0.69898253 |
| 81 | CAMK2A | 0.69256939 |
| 82 | MARK2 | 0.69236226 |
| 83 | RET | 0.68989732 |
| 84 | CDK8 | 0.66249173 |
| 85 | NUAK1 | 0.65238006 |
| 86 | WNK1 | 0.63650120 |
| 87 | STK3 | 0.62469582 |
| 88 | TGFBR2 | 0.61342945 |
| 89 | LRRK2 | 0.60843970 |
| 90 | PRKG2 | 0.60318355 |
| 91 | PRKCE | 0.60045912 |
| 92 | MAP3K5 | 0.60014208 |
| 93 | BCKDK | 0.59788531 |
| 94 | KSR1 | 0.59188732 |
| 95 | CAMK1 | 0.57252229 |
| 96 | EPHB1 | 0.56868872 |
| 97 | SGK3 | 0.56365245 |
| 98 | CAMK2G | 0.55881159 |
| 99 | MAP3K6 | 0.55072680 |
| 100 | RPS6KA2 | 0.54203137 |
| 101 | PAK6 | 0.54195697 |
| 102 | NME1 | 0.53230124 |
| 103 | ERBB3 | 0.53097548 |
| 104 | SIK1 | 0.51755385 |
| 105 | ROCK2 | 0.50441937 |
| 106 | PDGFRB | 0.50166035 |
| 107 | OXSR1 | 0.47845300 |
| 108 | MAPK11 | 0.46456458 |
| 109 | PDK1 | 0.46401470 |
| 110 | NTRK1 | 0.46371612 |
| 111 | DAPK3 | 0.45733575 |
| 112 | GSK3A | 0.45653639 |
| 113 | JAK1 | 0.43722824 |
| 114 | CAMKK1 | 0.43288315 |
| 115 | FLT3 | 0.43055621 |
| 116 | GRK7 | 0.42850618 |
| 117 | CAMK2B | 0.41156213 |
| 118 | ERN1 | 0.40346731 |
| 119 | FGFR2 | 0.40308409 |
| 120 | ZAK | 0.40161269 |
| 121 | BRSK2 | 0.39728387 |
| 122 | SGK2 | 0.39249925 |
| 123 | CAMK4 | 0.38601144 |
| 124 | MAPK12 | 0.38520490 |
| 125 | ABL2 | 0.38019674 |
| 126 | EEF2K | 0.37929555 |
| 127 | RAF1 | 0.37734566 |
| 128 | MAP3K4 | 0.36974579 |
| 129 | SGK1 | 0.36605880 |
| 130 | ADRBK1 | 0.34392738 |
| 131 | MAP3K13 | 0.32129906 |
| 132 | SCYL2 | 0.31581482 |
| 133 | PRKG1 | 0.22979552 |
| 134 | AKT2 | 0.22559123 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 3.38747068 |
| 2 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 3.03903415 |
| 3 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 2.95805370 |
| 4 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 2.53741521 |
| 5 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 2.47262892 |
| 6 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.45548478 |
| 7 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.92599739 |
| 8 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.78857757 |
| 9 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.72827655 |
| 10 | Tight junction_Homo sapiens_hsa04530 | 1.56348204 |
| 11 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.54091750 |
| 12 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.52214283 |
| 13 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.50694537 |
| 14 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.49308260 |
| 15 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.42838097 |
| 16 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.33301224 |
| 17 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.32877747 |
| 18 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.27257662 |
| 19 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.27247849 |
| 20 | * Adherens junction_Homo sapiens_hsa04520 | 1.26939971 |
| 21 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 1.26478684 |
| 22 | Focal adhesion_Homo sapiens_hsa04510 | 1.21452751 |
| 23 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.21124883 |
| 24 | Renin secretion_Homo sapiens_hsa04924 | 1.20931481 |
| 25 | Mineral absorption_Homo sapiens_hsa04978 | 1.19408536 |
| 26 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.18759279 |
| 27 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.17380101 |
| 28 | Carbon metabolism_Homo sapiens_hsa01200 | 1.14819221 |
| 29 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.13462037 |
| 30 | Circadian entrainment_Homo sapiens_hsa04713 | 1.13265189 |
| 31 | Insulin secretion_Homo sapiens_hsa04911 | 1.11135197 |
| 32 | Salivary secretion_Homo sapiens_hsa04970 | 1.08985243 |
| 33 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.08188376 |
| 34 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.07548946 |
| 35 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 1.05405051 |
| 36 | Long-term potentiation_Homo sapiens_hsa04720 | 1.04809771 |
| 37 | Bile secretion_Homo sapiens_hsa04976 | 1.02043253 |
| 38 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.00549655 |
| 39 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.99366675 |
| 40 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.99324389 |
| 41 | Insulin resistance_Homo sapiens_hsa04931 | 0.97501125 |
| 42 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.97292009 |
| 43 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.96685904 |
| 44 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.95887998 |
| 45 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.95730053 |
| 46 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.95464673 |
| 47 | Histidine metabolism_Homo sapiens_hsa00340 | 0.94600290 |
| 48 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.93340916 |
| 49 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.91570635 |
| 50 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.90202277 |
| 51 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.90183930 |
| 52 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.88436060 |
| 53 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.88362349 |
| 54 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.87982447 |
| 55 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.86432609 |
| 56 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.84691822 |
| 57 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.84112492 |
| 58 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.84005998 |
| 59 | Melanoma_Homo sapiens_hsa05218 | 0.82355581 |
| 60 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.82340320 |
| 61 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.82133936 |
| 62 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.81821130 |
| 63 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.81763740 |
| 64 | Amoebiasis_Homo sapiens_hsa05146 | 0.81568644 |
| 65 | Circadian rhythm_Homo sapiens_hsa04710 | 0.81323331 |
| 66 | Viral myocarditis_Homo sapiens_hsa05416 | 0.81150950 |
| 67 | Olfactory transduction_Homo sapiens_hsa04740 | 0.79542039 |
| 68 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.78198814 |
| 69 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.77145132 |
| 70 | Gap junction_Homo sapiens_hsa04540 | 0.76773289 |
| 71 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.76467268 |
| 72 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.75628970 |
| 73 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.74851072 |
| 74 | Alzheimers disease_Homo sapiens_hsa05010 | 0.73917204 |
| 75 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.73489069 |
| 76 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.73415172 |
| 77 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.73321117 |
| 78 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.72530011 |
| 79 | Taste transduction_Homo sapiens_hsa04742 | 0.71241893 |
| 80 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.70533905 |
| 81 | Pathways in cancer_Homo sapiens_hsa05200 | 0.70155132 |
| 82 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.69178351 |
| 83 | Bladder cancer_Homo sapiens_hsa05219 | 0.68347844 |
| 84 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.68286563 |
| 85 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.68173485 |
| 86 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.67601844 |
| 87 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.67345450 |
| 88 | Platelet activation_Homo sapiens_hsa04611 | 0.66036150 |
| 89 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.65732084 |
| 90 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.64881938 |
| 91 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.64775685 |
| 92 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.64615562 |
| 93 | Endometrial cancer_Homo sapiens_hsa05213 | 0.64333140 |
| 94 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.63912423 |
| 95 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.62299246 |
| 96 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.60957780 |
| 97 | Lysine degradation_Homo sapiens_hsa00310 | 0.60112197 |
| 98 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.59956429 |
| 99 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.59761451 |
| 100 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.59724319 |
| 101 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.59704313 |
| 102 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.59112141 |
| 103 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.59046604 |
| 104 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.59028580 |
| 105 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.58663385 |
| 106 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.58403049 |
| 107 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.57442054 |
| 108 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.57088326 |
| 109 | Endocytosis_Homo sapiens_hsa04144 | 0.57086586 |
| 110 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.56634375 |
| 111 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.56128898 |
| 112 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.56092511 |
| 113 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.55915020 |
| 114 | Melanogenesis_Homo sapiens_hsa04916 | 0.55799847 |
| 115 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.55041515 |
| 116 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.54844806 |
| 117 | Parkinsons disease_Homo sapiens_hsa05012 | 0.54783789 |
| 118 | Galactose metabolism_Homo sapiens_hsa00052 | 0.54604319 |
| 119 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.54130312 |
| 120 | Pertussis_Homo sapiens_hsa05133 | 0.54011650 |
| 121 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.54004278 |
| 122 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.53814034 |
| 123 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.53319103 |
| 124 | ABC transporters_Homo sapiens_hsa02010 | 0.53132822 |
| 125 | Prostate cancer_Homo sapiens_hsa05215 | 0.52958850 |
| 126 | Cocaine addiction_Homo sapiens_hsa05030 | 0.52656429 |
| 127 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.52570721 |
| 128 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.52143971 |
| 129 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.51872676 |
| 130 | Glioma_Homo sapiens_hsa05214 | 0.51402077 |
| 131 | Other glycan degradation_Homo sapiens_hsa00511 | 0.51251737 |
| 132 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.51231007 |
| 133 | Axon guidance_Homo sapiens_hsa04360 | 0.49684801 |
| 134 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.49590612 |
| 135 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.47927645 |
| 136 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.47746002 |
| 137 | Thyroid cancer_Homo sapiens_hsa05216 | 0.46246127 |
| 138 | Retinol metabolism_Homo sapiens_hsa00830 | 0.44094298 |
| 139 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.40313704 |

